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Members of the carcinoembryonic antigen (CEA) family include CEA, non-specific ross reacting antigen (NCA), and bthary glycoprotem (BGP). 
and appear to function as cell adhesion molecules. Immunoprecipitation and subsequent gel electrophoresis of proteins from several colon cancer 
cell lines labeled with [y-3ZP]ATP, under conditions designed to detect ecto-kinase-catalyzed phosphorylation of cellular proteins, revealed that 
polyclonal anti-CEA antiserum recognized a 175-190 kDa phosphoprotein on the surface of colon cancer cells. The ability to detect this 
phosphoprotein did not correlate with CEA production, and immunoprecipitation studies suggested that the phosphoprotein is BGP. Phospho- 
amino acid analysis of the 175-190 kDa protein showed that it contained predominantly phosphotyrosine. 
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1. INTRODUCTION 
Carcinoembryonic antigen (CEA) was first described 
as a 180 kDa tumor-associated cell surface glycoprotein 
on colon cancer cells [1,2]. Subsequently, a number of 
closely related, cross-reacting antigens have been found 
in normal cells [3-61. The CEA gene belongs to a family 
of at least 20 closely related genes which belong to the 
immunoglobulin gene superfamily [3-61. The CEA gene 
family consists of two major subgroups. The CEA sub- 
group contains genes that encode CEA, non-specific 
cross reacting antigen (NCA), and biliary glycoprotein 
(BGP), while the other subgroup consists of genes that 
encode the pregnancy-specific glycoproteins [6]. The 
general structure of members of the CEA family con- 
sists of a 34 amino acid hydrophobic leader sequence, 
an N-terminal domain of 107-110 amino acids that is 
similar to the immunoglobulin variable domain, and a 
variable number of immunoglobulin C2-like domains, 
in addition to a short hydrophobic carboxy-terminal 
region that is post-translationally modified to allow 
membrane anchoring via a glycosyl-phosphatidylinosi- 
to1 linkage [5,7]. The different members of the CEA 
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family can be distinguished by the number of repeated 
C2 subunits; CEA consists of 6 repeats, NCA has 2 
repeats, and BGP has 3 repeats. Until recently, all CEA 
and NCA molecules were thought to be linked to the 
plasma membrane via a glycosyl-phosphatidylinositol 
linkage [8811]. In contrast, BGP has been shown to 
have a transmembrane domain and a cytoplasmic do- 
main [11,12]. Members of the CEA family appear to 
function as cellLcel1 adhesion molecules [ 133151. 
Protein phosphorylation is an important mechanism 
of regulation of cell function. Although most studies of 
protein phosphorylation have been directed at intracel- 
lular reactions, evidence has been provided for the exis- 
tence of ecto-protein kinase activity on the surface of 
several different types of cells (reviewed in [ 166181). This 
ecto-protein kinase is capable of utilizing extracellular 
ATP to phosphorylate exogenous substrates as well as 
endogenous surface proteins. The role of ecto-protein 
kinase activities in cell function is unknown. One of the 
major endogenous substrates for human neutrophil 
ecto-protein kinase activity was phosphorylated pre- 
dominantly on tyrosine residues and was immunopre- 
cipitated by both CD1 5 and CD66 monoclonal antibod- 
ies [ 19,201. This protein is also recognized by polyclonal 
anti-CEA and thus may represent BGP [20]. In addi- 
tion, CD66 antibodies were found to react with CEA, 
NCA, and BGP [20]. We thus questioned whether CEA 
or related proteins might be phosphorylated in colon 
cancer cells. This report demonstrates that polyclonal 
anti-CEA recognizes a - 175-l 90 kDa phosphoprotein 
in several human colon cancer cell lines. Phosphoryla- 
tion of this protein was detectable when cells were radi- 
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olabeled in the presence of [T-~~P]ATP utilizing a tech- 
nique designed to detect ecto-protein kinase activity, 
but was not detected when cells were metabolically radi- 
olabeled with H,32P0,. Phosphoamino acid analysis of 
this protein revealed that it contained predominantly 
phosphotyrosine with a lower level of phosphothreon- 
ine/phosphoserine. 
2. MATERIALS AND METHODS 
2.1. Cell lines 
The human colon cancer cell lines COLO 201, COLO 205 [21], HCT 
116 [22], and LoVo [23], were obtained from the American Type 
Culture Collection, Rockville. MD. The colon cancer cell lines KM12 
and KM12SM [24], melanoma cell lines A375 and A375SM [25], and 
renal cell carcinoma cell lines SN12 and SN12PM-6 [26] were gifts of 
Dr. I. Fidler. MD Anderson Cancer Center, Houston, TX. 
2.2. 32P-Labelmg 
Cells were radiolabeled with 32P by using two different techniques. 
In the first method, 2.5 x 10’ cells were incubated for 2 h at 37°C in 
750 ,rd of a buffer containing 145 mM NaCI, 20 mM HEPES, pH 7.4, 
1 mM MnC&, 1 mM Na,VO,, 1 mM NarMoO,, and 5 mCi of “PO, 
(carrier-free orthophosphate, Amersham). DFP was then added to 10 
mM and the cells incubated for 5 min at 23°C. The cells were then 
collected by centrifugation at 9,800 x g for 2 min and solubilized and 
analyzed as described below. 
In the second labeling procedure [19,20], 2 x 10’ cells were incu- 
bated for 15 min at 23°C in 1 ml of a buffer containing 1 mM MnCI,, 
145 mM NaCI, 20 mM HEPES, pH 7.4, 1 mM Na,VO,, 1 mM 
Na,MoO,, and 0.5 mCi [y-3ZP]ATP (specific activity 4,500 Ci/mmol, 
ICN. Irvine, CA). These conditions were previously found to result 
in efficient protein radiolabeling by ecto kinase activity [19,20]. At the 
end of the mcubation. DFP was added to 10 mM, the cells were 
incubated 23°C for 5 min. and recovered by centrifugation at 9,800 x g 
for 2 mm. The cells were then solubilized and analyzed as described 
below. 
2.3. Immunoprecipitatron and PAGE 
Immunoprecipitation was performed as previously described [20]. 
Briefly, 2 x 10’ radiolabeled cells were suspended in 1.2 ml of cell 
solubilization buffer (20 mM Tris-HCI, pH 7.6, 150 mM NaCI, 0.5% 
NP-40,1 mM Na,VO,,, 1 mM Na,MoO,, 100 PM ATP, 0.02% NaN,. 
and 1 mM phenylmethylsulfonylfluoride (PMSF)) and incubated on 
ice for 15 min. The suspensions were then centrifuged at 9,800 x g for 
15 min at 4”C, and the supematant used for immunoprecipitation or 
analyzed by SDS-PAGE directly. Rabbit anti-CEA was obtained from 
Accurate Chemical Corp., Westbury, NY. Monoclonal antibody 
T84.1, which recognizes CEA and BGP, and monoclonal antibody 
T84.6. which recognizes CEA but not BGP, were gifts of Drs. R. 
Paxton and S. Hefta, City of Hope, Duarte, CA. 
2.4. Phosphoamino acid analyses 
Phosphoamino acid analyses were performed as previously de- 
scribed [27]. Briefly, radiolabeled polypeptides resolved by SDS- 
PAGE were localized by autoradiography, excised, and eluted from 
gel slices. After precipitation with 20% TCA, the polypeptides were 
subjected to acid hydrolysis in vacua in 6 M HCI at 100°C for 34 h, 
and the resultant phosphoamino acids were resolved by one-dimen- 
sional thin layer chromatography on aluminum sheets precoated with 
silica gel (0.2 mm layer thickness, 11 cm height) (Merck Laboratories, 
EM Science, Gibbstown, NJ) in ethanol: 25% NH,OH (3.5:1.6). The 
chromatography cycle was repeated three times to achieve optimal 
separation. Between cycles, plates were air dried followed by chroma- 
tography in the same solvent. 
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Fig. 1. Immunoprecipitation and SDS-PAGE of colon cancer, mela- 
noma, and renal cell cancer cells radiolabeled with [y-r2P]ATP. KM12 
(lanes A and C), KMl2SM (lanes B and D), A375 (lane E), A375SM 
(lane F), SN12 (lane G), and SN12PM-6 (lane H) cells were radiola- 
beled with 32P by the addition of [y-32P]ATP, solubilized, and im- 
munoprecipitated with rabbit anti-CEA (lanes A,B and E-H) or NRS 
(lanes C,D), and analyzed by SDS-PAGE and autoradiography as 
described in the text. Proteins used as molecular weight standards 
were: myosin heavy chain, 200,000; E. coli /3-galactosidase, 116,000; 
phosphorylase a, 97,400; BSA, 66,000; and ovalbumin, 45,000. 
3. RESULTS 
3.1. Immunoprecipitation f 32P-labeledproteins byanti- 
CEA 
To determine if proteins recognized by anti-CEA in 
colon cancer cell lines were phosphorylated, two ap- 
proaches to radiolabeling were taken. First, viable 
KMl2, KM12SM, COLO 201, and COLO 205 cells 
were incubated with H,32P04 to metabolically radiola- 
beled phosphoproteins. However, anti-CEA did not im- 
munoprecipitate any detectable 32P-labeled proteins 
from these cell lysates (not shown). In the second ap- 
proach, based on previous studies with neutrophils [20], 
viable colon cancer cells were incubated with [y- 
32P]ATP, a technique designed to detect phosphopro- 
teins whose phosphorylation is catalyzed by intrinsic 
ecto-protein kinase activity. This labeling technique re- 
sulted in 32P incorporation into several proteins, with 
most 32P incorporation found in proteins of -120-250 
kDa (not shown). Immunoprecipitation of extracts of 
KM12 cells radiolabeled in this manner with anti-CEA 
resulted in the identification of a 32P-labeled protein of 
-175-190 kDa (Fig. I, lane A). A -125-145 kDa 32P- 
labeled protein of lower intensity was also seen. Normal 
rabbit serum (NRS) did not immunoprecipitate these 
201 
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Fig. 2. Immunoprecipitation and SDS-PAGE of “P-labeled proteins 
from colon cancer cells radiolabeled with [y-“P]ATP. Co10 201 (lanes 
A and B) and Co10 205 (lanes C and D) cells were radiolabeled with 
“P by the addition of [y-3’P]ATP, solubthzed, and tmmunoprecipi- 
tated with rabbit anti-CEA (lanes A and C) or NRS (lanes B and D). 
and analyzed as in Fig. 1. 
proteins (lane C): Anti-CEA also immunoprecipitated 
32P-labeled proteins of similar molecular weight from 
extracts of KM12SM cells radiolabeled by this tech- 
nique (lane B) while NRS did not (lane D). 
Four other cell ines, A375, A375SM (melanoma), 
SN12, and SN12PM-6 (renal cell carcinoma), were also 
radiolabeled by this technique; however, anti-CEA did 
not immunoprecipitate any 32P-labeled proteins from 
extracts of A375 (Fig. 1, lane E), A375SM (lane F), 
SN12 (lane G), or SN12PM-6 (lane H) cells. To further 
characterize the phosphorylation of CEA-related mole- 
cules, four other colon cancer cell lines with various 
levels of CEA production were analyzed. HCT 116 pro- 
duces CEA at a low level (-1 ng/106 cells/ml/l0 days) 
[28] while LoVo produces CEA at a high level (-900 
r&O6 cells/ml/l0 days) [28]. However, anti-CEA did 
not immunoprecipitate any detectable 32P-labeled pro- 
teins from extracts of either LoVo or HCT 116 cells (not 
shown). In contrast, anti-CEA immunoprecipitated two 
32P-labeled proteins of -1755190 kDa and 125-145 
kDa from both COLO 201 (Fig. 2. lane A) and COLO 
202 
205 (lane C) while NRS (lanes B and D) did not. COLO 
205 produces CEA at a low level (-2 ng/106 cells/ml/l0 
days) [28] while COLO 201 does not produce CEA [28]. 
However, COLO 201 and COLO 205 produce similar 
amounts of BGP [13]. T84.1 immunoprecipitated the 
same 32P-labeled proteins from KM12 cells as did poly- 
clonal anti-CEA (not shown). This monoclonal anti- 
body recognizes CEA and BGP [29]. In contrast, T84.6 
recognizes CEA. but not BGP [29], and did not im- 
munoprecipitate these proteins (not shown). We con- 
clude that the 3”P-labeled 175-190 kDa protein is BGP. 
3.2. Characterization of the phosphorylation of the 
phosphoproteins recognized by anti-CEA 
To determine the identity of the “P-labeled amino 
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Fig. 3. Phosphoamino acid analysis of phosphoprotein recognized by 
anti-CEA from KM12 (lane A) and KMl2SM (lane B) cells. Cells 
were “‘P-labeled by the addition of [y-‘ZP]ATP, solubilized, and im- 
munoprecipitated by anti-CEA. The 1755190 kDa phosphoprotem 
immunoprectpitated by anti-CEA was resolved by SDS-PAGE as in 
Fig. 1. excised, eluted from the gel slice, and sublected to acid hydrol- 
ysis. The resultant phosphoamino acids were resolved by thin layer 
chromatography and visualized by autoradiography as described in 
the text. The positions of migration of authentic phosphoserme (P-S), 
phosphothreonme (P-T), and phosphotyrosine (P-Y) are indtcated by 
dotted lines. 
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Fig. 4. Phosphoamino acid analysis of whole cell extracts of KM12 
cells labeled metabolically by incubation with H,32P04 (lane A) or by 
the addition of [y-“P]ATP (lane B). Cells were radiolabeled by incuba- 
tion with H,32P04 or [y-“P]ATP as described in the text, solubihzed, 
and the soluble proteins were resolved by SDS-PAGE, eluted from the 
gel, and subjected to acid hydrolysis. The resultant phosphoamino 
acids were resolved by thin layer chromatography and visualized by 
autoradiography as in Fig. 3. 
acid residues in the proteins recognized by anti-CEA 
when colon cancer cells were labeled with [y-32P]ATP, 
the protein was analyzed for its phosphoamino acid 
composition. The majority of 32P identified was in 
phosphotyrosine residues (Fig. 3) with a lower level of 
phosphothreonine/phosphoserine. To further explore 
the nature of the 32P incorporation into cellular proteins 
observed with the addition of [Y-~~P]ATP and H332P04, 
extracts of whole cells labeled by these two techniques 
were analyzed directly for their total phosphoamino 
acid content. When KM12 cells were metabolically la- 
beled with H332P0,, most of the 32P was incorporated 
into serine residues with little incorporation into tyro- 
sine residues (Fig. 4, lane A). In contrast, when cells 
were radiolabeled by the addition of [Y-~~P]ATP, much 
of the 32P was found in tyrosine residues in addition to 
serine and threonine residues (lane B). 
4. DISCUSSION 
CEA is widely used as a tumor marker, and is one of 
a family of more than 20 genes including NCA and BGP 
which form a subset of the immunoglobulin gene super- 
family [6]. Recent studies have suggested that CEA, 
NCA, and BGP function as cell adhesion molecules 
[13-l 51. The demonstration that CD66 antibodies react 
with CEA, NCA, and BGP, and also recognize a 180 
kDa neutrophil membrane protein that is 
phosphorylated under conditions designed to detect 
ecto-protein kinase activity [20] led us to look for phos- 
phorylation of CEA in colon cancer cells. 
In this study, phosphorylation of the CEA-reactive 
protein was detected when cells were labeled by the 
addition of [Y-~~P]ATP but not by incubation with 
H33’P0,. These results are consistent with phosphoryla- 
tion of an external domain by an ecto-protein kinase, 
as was hypothesized for CD66 [20], but may represent 
phosphorylation of a cytoplasmic domain. Clearly, the 
two 32P-labeling techniques result in very different pat- 
terns of protein phosphorylation. In particular, as ex- 
pected since phosphotyrosine is felt to represent c 1% 
of the phosphorylated residues in total cellular protein 
[27], metabolic radiolabeling with H332P04 resulted in 
most of the 32P in the whole cell extract being incorpo- 
rated into serine residues with little incorporation into 
tyrosine. In contrast, when cells were radiolabeled by 
the addition of [y-32P]ATP. much of the 32P in the whole 
cell extract was incorporated into tyrosine residues, in 
addition to serine and threonine. However, definitive 
identification of the phosphorylation site will require 
further structural studies. 
Phosphoamino acid analysis revealed that most of the 
32P identified in the anti-CEA reactive protein was in 
phosphotyrosine residues with a lower level of 
phosphothreonine/phosphoserine. Receptors for a 
number of growth factors are phosphorylated on tyro- 
sine; these receptors have intrinsic tyrosine-kinase activ- 
ity, and their activities may be regulated by phosphoryl- 
ation [30-331. In addition, phosphorylation of other cell 
adhesion molecules has been suggested to be a mecha- 
nism of regulating their adhesion functions [34-381. 
It is noteworthy that the ability to immunoprecipitate 
a 32P-labeled protein with anti-CEA from the colon can- 
cer cell lines tested did not correlate well with the re- 
ported CEA production by the cell lines. LoVo cells 
produce CEA at a very high level [28], but anti-CEA did 
not immunoprecipitate any detectable 3’P-labeled pro- 
teins from these cells. However, anti-CEA did im- 
munoprecipitate a 3’P-labeled protein from COLO 205 
cells, which produce CEA at -0.2% the rate of produc- 
tion by LoVo cells, and also from COLO 201 cells, 
which do not produce detectable CEA [28]. These re- 
sults suggest that the phosphoprotein observed in this 
study is a member of the CEA family but not CEA itself. 
This conclusion is supported by the ability to im- 
203 
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munoprecipitate the phosphoprotein by T84.1, which 
recognizes CEA and BGP, but not by T84.6, which 
recognizes CEA but not BGP. Thus, the data suggest 
that the 175-190 kDa phosphoproteins are forms of 
BGP. 
Recently, Afar et al., reported that BGP, and BGP, 
can be phosphorylated on serine and tyrosine residues 
in LR-73 cells transfected with cDNAs for these pro- 
teins [39]. These proteins were also phosphorylated in 
KG-1 leukemia cells. Interestingly, they detected phos- 
phorylation of BGP, and BGP, when cells were labeled 
with H,32P0, but not with [T-~~P]ATP, and concluded 
that the most likely site of phosphorylation is in the 
cytoplasmic domain. The reason for these differences 
may lie in the conditions under which the incubation 
with [T-~~P]ATP was performed. Regardless, the phos- 
phorylation of the CEA-reactive protein on tyrosine 
observed here suggests a potential role of phosphoryla- 
tion in the regulation of its function. 
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